HIV

Reservoirs and Eradication

• Todd Allen, PhD: Viral evolution from host cellular and humoral responses in HIV and HCV
• Galit Alter, PhD: Innate immune responses to chronic viral infections
• Dan Barouch, MD: HIV immunology and development of novel vaccine and eradication strategies
• Rajesh Gandhi, MD: Studies of HIV reservoirs and immune-based therapies, including clinical trials
• Boris Juelg, MD, PhD: Immunotherapies for the prevention and treatment of infectious diseases
• Dan Kuritzkes, MD: Studies on HIV therapeutics, antiretroviral drug resistance, HIV-1 persistence and eradication
• Douglas Kwon, MD, PhD: Host-microbe interactions in the gut, lung, and female genital tract in HIV infection
• Jonathan Li, MD: HIV drug resistance, persistence, and cure
• Mathias Lichterfeld, MD, PhD: HIV immune defense mechanisms and clinical development of HIV eradication/cure strategies
• Eric Rosenberg, MD: Mechanisms of successful cellular immune responses to HIV
• Athe Tsibris, MD: HIV reservoirs and cure

Vaccines

• Todd Allen, PhD: Viral evolution from host cellular and humoral responses in HIV and HCV
• Galit Alter, PhD: Innate immune responses to chronic viral infections
• Lindsey Baden, MD: Vaccines and infectious complications of immunosuppression
• Boris Juelg, MD, PhD: Immunotherapies for the prevention and treatment of infectious diseases
• Dan Barouch, MD: HIV immunology and development of novel vaccine and eradication strategies
• Douglas Kwon, MD, PhD: Host-microbe interactions in the gut, lung, and female genital tract in HIV infection
• Bruce Walker, MD: Cellular Mechanisms of HIV Control

Resistance and Clinical Trials

• Lindsey Baden, MD: Vaccines and infectious complications of immunosuppression
• Scott Dryden-Peterson, MD, MSc: Programmatic and implementation trials in HIV and cancer care; HIV treatment and prevention clinical trials (ACTG, IMPAACT, HPTN); Cervical cancer prevention trials (CASCADE)
• Rajesh Gandhi, MD: Studies of HIV reservoirs and immune-based therapies, including clinical trials
• Boris Juelg, MD, PhD: Immunotherapies for the prevention and treatment of infectious diseases
• Dan Kuritzkes, MD: Studies on HIV therapeutics, antiretroviral drug resistance, HIV-1 persistence and eradication
• Jonathan Li, MD: HIV drug resistance, persistence, and cure
• Mathias Lichterfeld, MD, PhD: HIV immune defense mechanisms and clinical development of HIV eradication/cure strategies
• Shahin Lockman, MD: HIV in developing countries
• Gregory Robbins, MD, MPH: Clinical decision support systems to improve HIV health outcomes
• Paul Sax, MD: Clinical trials and cost-effectiveness of HIV therapy
• Bruce Walker, MD: Cellular Mechanisms of HIV Control

Adherence

• Mark Siedner, MD: Improving health and quality of life for people with HIV in sub-Saharan Africa

International

• Dan Barouch, MD: HIV immunology and development of novel vaccine and eradication strategies
• Ingrid Bassett, MD, MPH: Increasing access to prevention and treatment for HIV and other infectious diseases
• Andrea Ciaranello, MD: Strategies to improve the care of HIV-infected women, children, and adolescents
• Caitlin Dugdale, MD: Simulation modeling and health policy to reduce vertical HIV transmission and improve global maternal-child health
• Scott Dryden-Peterson, MD, MSc: Effect of HIV on cancer risk and oncologic outcomes; Programmatic and implementation trials in HIV and cancer care; HIV treatment and prevention clinical trials (ACTG, IMPAACT, HPTN); Cervical cancer prevention trials (CASCADE)
• Kenneth Freedberg, MD, MSc: Clinical outcomes and health policy in chronic disease
• Emily Hyle, MD MSc DTM&H (Gorgas): Epidemiology, health policy, and simulation modeling in HIV and travel medicine
• Dan Kuritzkes, MD: Studies on HIV therapeutics, antiretroviral drug resistance, HIV-1 persistence and eradication
• Douglas Kwon, MD, PhD: Host-microbe interactions in the gut, lung, and female genital tract in HIV infection
• Jonathan Li, MD, MMSc: HIV and SARS-CoV-2 drug resistance, persistence, and cure
• Shahin Lockman, MD: HIV in developing countries
• Anne Neilan, MD MPH: Epidemiology, health policy, and simulation modeling among adolescents and young adults living with and at risk of HIV
• Mark Siedner, MD: Improving health and quality of life for people with HIV in sub-Saharan Africa
• Bruce Walker, MD: Cellular Mechanisms of HIV Control

Modeling and Outcomes

• Ruanne V. Barnabas, MBChB, DPhil: Clinical trials and economic modeling to increase access to prevention and treatment of infectious diseases
• Ingrid Bassett, MD, MPH: Increasing access to prevention and treatment for HIV and other infectious diseases
• Andrea Ciaranello, MD: Strategies to improve the care of HIV-infected women, children, and adolescents
• Caitlin Dugdale, MD: Simulation modeling and health policy to reduce vertical HIV transmission and improve global maternal-child health
• Kenneth Freedberg, MD, MSc: Clinical outcomes and health policy in chronic disease
• Emily Hyle, MD MSc DTM&H (Gorgas): Epidemiology, health policy, and simulation modeling in HIV and travel medicine
• Anne Neilan, MD MPH: Epidemiology, health policy, and simulation modeling among adolescents and young adults living with and at risk of HIV
• Paul Sax, MD: Clinical trials and cost-effectiveness of HIV therapy
• Virginia Triant, MD, MPH: Outcomes research on non-communicable/aging-related diseases and HIV